全文获取类型
收费全文 | 158420篇 |
免费 | 9812篇 |
国内免费 | 1593篇 |
专业分类
耳鼻咽喉 | 1435篇 |
儿科学 | 4808篇 |
妇产科学 | 3823篇 |
基础医学 | 21517篇 |
口腔科学 | 5077篇 |
临床医学 | 14126篇 |
内科学 | 36072篇 |
皮肤病学 | 3592篇 |
神经病学 | 15191篇 |
特种医学 | 4386篇 |
外国民族医学 | 3篇 |
外科学 | 16236篇 |
综合类 | 2515篇 |
现状与发展 | 1篇 |
一般理论 | 53篇 |
预防医学 | 13605篇 |
眼科学 | 2436篇 |
药学 | 11766篇 |
8篇 | |
中国医学 | 1412篇 |
肿瘤学 | 11763篇 |
出版年
2024年 | 208篇 |
2023年 | 1494篇 |
2022年 | 3375篇 |
2021年 | 5411篇 |
2020年 | 3457篇 |
2019年 | 4350篇 |
2018年 | 4924篇 |
2017年 | 3811篇 |
2016年 | 4323篇 |
2015年 | 4930篇 |
2014年 | 6480篇 |
2013年 | 8362篇 |
2012年 | 12239篇 |
2011年 | 12646篇 |
2010年 | 7072篇 |
2009年 | 6110篇 |
2008年 | 10225篇 |
2007年 | 10335篇 |
2006年 | 9487篇 |
2005年 | 8884篇 |
2004年 | 7961篇 |
2003年 | 7045篇 |
2002年 | 6412篇 |
2001年 | 1992篇 |
2000年 | 1736篇 |
1999年 | 1863篇 |
1998年 | 1316篇 |
1997年 | 1037篇 |
1996年 | 944篇 |
1995年 | 769篇 |
1994年 | 711篇 |
1993年 | 606篇 |
1992年 | 973篇 |
1991年 | 781篇 |
1990年 | 764篇 |
1989年 | 737篇 |
1988年 | 641篇 |
1987年 | 578篇 |
1986年 | 568篇 |
1985年 | 442篇 |
1984年 | 405篇 |
1983年 | 350篇 |
1982年 | 281篇 |
1981年 | 219篇 |
1980年 | 219篇 |
1979年 | 292篇 |
1978年 | 206篇 |
1977年 | 185篇 |
1974年 | 184篇 |
1973年 | 162篇 |
排序方式: 共有10000条查询结果,搜索用时 33 毫秒
101.
Marco Maruzzo Umberto Basso Eugenio Borsatti Laura Evangelista Filippo Alongi Orazio Caffo Francesca Maines Sara Galuppo Rocco De Vivo Fable Zustovich Dario Palleschi Andrea Zivi Teodoro Sava Mariella Sorarù Roberto Iacovelli Maurizio Nicodemo Susanne Baier Lucia Fratino Vittorina Zagonel 《Clinical genitourinary cancer》2019,17(1):e187-e194
Background
Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.Patients and Methods
We conducted a multicenter retrospective analysis in the Triveneto region of Italy.Results
One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.Conclusion
This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined. 相似文献102.
M. Novi C. Vanni P. D. Parchi M. Di Paolo N. Piolanti M. Scaglione 《Musculoskeletal surgery》2020,104(1):43-48
Over the years, the number of total hip replacements has been steadily increasing. Despite the improvement in surgical results, the number of claims for malpractice is higher. The primary endpoint of this work is to provide an analysis of litigation after hip replacement, to outline what are the instigating causes and costs. The secondary endpoint is to propose a possible preventive strategy for an improved care and a reduction in legal proceedings. The data of this study were collected from medical and legal files and from professional liability insurance of our institution from January 2005 to December 2016. Out of a total of 4770 THA, 40 claims were received. Peripheral nerve injuries represent the first cause of litigation (37%), followed by infectious complications, leg length discrepancy, metallosis, dislocations of the implant and a case of deep vein thrombosis. From the analysis of the past trial judgment, complications such as nerve lesions and infections are almost always recognized, as a medical error, with a high percentage of claims settled. This study shows the necessity of preventive strategies to reduce the higher number of claims for malpractice in total hip arthroplasty. Some complications such as nerve injuries and infection are frequently considered directly dependent on physician’s errors. Litigations can be reduced providing evidence of a diligent execution of the surgical procedure and of a proper postoperative management: the correct compilation of a specific informed consent and adequate doctor–patient communication. 相似文献
103.
Marie Warrer Petersen Tine Sylvest Meyhoff Marie Helleberg Maj-Brit Nørregaard Kjær Anders Granholm Carl Johan Steensen Hjortsø Thomas Steen Jensen Morten Hylander Møller Peter Buhl Hjortrup Mik Wetterslev Gitte Kingo Vesterlund Lene Russell Vibeke Lind Jørgensen Klaus Tjelle Thomas Benfield Charlotte Suppli Ulrik Anne Sofie Andreasen Thomas Mohr Morten H. Bestle Lone Musaeus Poulsen Mette Friberg Hitz Thomas Hildebrandt Lene Surland Knudsen Anders Møller Christoffer Grant Sølling Anne Craveiro Brøchner Bodil Steen Rasmussen Henrik Nielsen Steffen Christensen Thomas Strøm Maria Cronhjort Rebecka Rubenson Wahlin Stephan Jakob Luca Cioccari Balasubramanian Venkatesh Naomi Hammond Vivekanand Jha Sheila Nainan Myatra Christian Gluud Theis Lange Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.104.
目的 观察SWIM技术治疗后循环大血管闭塞所致急性缺血性卒中的有效性及安全性。
方法 回顾性分析2017年2月-2018年11月于大连市中心医院采用SWIM技术治疗的后循环大血管闭
塞所致急性缺血性卒中患者的临床资料,评价该技术的疗效和安全性,并分析影响患者预后的因素。
观察指标为术后即刻成功再通(mTICI≥2b)、90 d良好预后(mRS评分≤2分),以及术后24 h任何颅内
出血、90 d全因死亡。
结果 共纳入35例患者,平均年龄66.1±12.1岁,男性26例(74.3%),基线NIHSS评分22(15~34)分。
术后即刻成功再通率为94.3%(33/35),90 d良好预后率为45.7%(16/35),24 h颅内出血率为17.1%
(6/35),90 d全因死亡率为37.1%(13/35)。单因素分析显示,基线NIHSS评分较低(P =0.001)、基
线后循环ASPECTS评分较高(P =0.016)、发病至到院时间较短(P =0.039)、发病至再通时间较短
(P =0.047)、血管成功再通率较高(P =0.036)以及饮酒比例较低(P =0.042)与良好预后相关。
结论 使用SWIM技术治疗后循环急性缺血性卒中相对安全、有效。 相似文献
105.
106.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
107.
108.
109.
Gianluca Gambarini Lucila Piasecki Gabriele Miccoli Gianfranco Gaimari Roberto Di Giorgio Dario Di Nardo Adham A Azim Luca Testarelli 《Australian endodontic journal : the journal of the Australian Society of Endodontology Inc》2019,45(2):154-162
This study evaluated the effect of new motions of the motor TriAuto ZX2 on the cyclic fatigue of endodontic instruments. Vortex Blue 35.06 instruments were divided into four groups (n = 10) and tested for fatigue in a curved artificial canal (90° and 2 mm radius) using the following motions: continuous rotation (CR), Optimum Torque Reverse (OTR) set at 180° and the Optimum Glide Path (OGP), which was tested at 90° and 240°. The time to fracture (TTF) and the lengths of the fractured fragments were recorded. The mean TTF was significantly different among the groups (anova , P < 0.05): OGP 90° (213.39 ± 27.45), OTR 180° (121.24 ± 17.03), OGP 240° (45.24 ± 5.61) and CR (8.43 ± 1.27). Weibull analysis confirmed the shortest life expectancy for CR and the longest survival for OGP at 90°. The resistance to fatigue was affected by motions and pre‐set angles. The proprietary movements that are currently available for endodontic instruments were classified according to their kinematics. 相似文献
110.